20340 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole; Oxazoles 1,3-Oxazoles, e.g. pemoline, trimethadione
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#302FIBROBLAST GROWTH FACTOR (FGF) 1 MUTANTS AND METHODS OF USE TO REDUCE BLOOD GLUCOSE
#303Method of treating or preventing Ras-mediated diseases
#304COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES
#305Allosteric modulators of nicotinic acetylcholine receptors
#306GLP-1 receptor modulators
#307Novel formulation of metaxalone
#308Fatty acids as anti-inflammatory agents
#309Immunomodulation by IAP inhibitors
#310Processes for preparing dolutegravir and cabotegravir and analogues thereof
#311SOLID DISPERSION FORMULATIONS OF ANTIVIRAL COMPOUNDS
#312Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
#313Neprilysin inhibitors
#314Compositions and methods for treating severe pain
#315Oxazoline and isoxazoline derivatives as CRAC modulators
#316Allosteric modulators of nicotinic acetylcholine receptors
#317UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS
#318ALKENYLDIARYLMETHANES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR ANTI-HIV-1 CHEMOTHERAPY
#319Method of treating polycystic kidney diseases with ceramide derivatives
#320Compositions and methods of treating cardiac fibrosis with ifetroban
#321Hepatitis B antiviral agents
#322Methods of treating or preventing multiple sclerosis
#323Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#324Inhibitors of Bcl-2
#325Neprilysin inhibitors
#326OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION
#327Use of Adelmidrol in the Treatment of Epithelial Dysfunctions
#328(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#329Cyclopropylamine compounds as histone demethylase inhibitors
#330Neprilysin inhibitors
#331Thiazole and oxazole-substituted arylamides as P2Xand P2Xantagonists
#332Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments
#3332-oxothiazole compounds and method of using same for chronic inflammatory disorders
#334Method for the Production of Commercial Nanoparticle and Microparticle Powders
#335Combination therapy to treat mycobacterium diseases
#336Compounds and methods for inducing chondrogenesis
#337Isoxazoline-substituted benzamide compound and pesticide
#338Oxazolidine-based compound and selective androgen receptor agonist comprising same
#339MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#340OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF
#341Histone deacetylase inhibitors and compositions and methods of use thereof
#342Isoxazoline hydroxamic acid derivatives as LpxC inhibitors
#343Amido-substituted azole compounds
#344Medicament for suppressing malignant tumor metastasis
#345THERAPEUTIC OR PROPHYLACTIC AGENT FOR MULTIPLE SCLEROSIS
#346Pharmaceutical compositions
#347Antiviral compounds and uses thereof
#348Inhibitors of the plasmodial surface anion channel as antimalarials
#349Castration-resistant prostate cancer
#350(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
#3513-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#352GLP-1 receptor modulators
#353Anticancer agent comprising aminoacetonitrile compound as active ingredient
#354Targeting Metabolic Adaptive Responses to Chemotherapy
#355COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#356Neprilysin inhibitors
#357Method of selectively inhibiting Ras-mediated tumor growth in humans
#358Inhibitors of human 12/15-lipoxygenase
#359Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders
#360METHODS OF TREATMENT WITH BIOAVAILABLE COMPOSITIONS OF METAXALONE COMPRISING NONVOLATILE LIQUIDS
#361Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#362OXAZOLIDINONE DERIVATIVES AS PPAR LIGANDS
#363Cyclopropaneamine compound
#364Inhibitors of cholesterol ester transfer protein
#365SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT IN THE ORAL CAVITY
#366Substituted phenylazole derivative
#367OXIMINO DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA
#368Neprilysin inhibitors
#369Antibody Buffering of a Ligand in Vivo
#370SUBSTITUTED PHENYLAZOLE DERIVATIVE
#371SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#372Inhibition of choroidal neovascularization
#373COMBINATIONS AND METHODS FOR TREATING NON AGE-RELATED HEARING IMPAIRMENT IN A SUBJECT
#374Oxazoline and isoxazoline derivatives as CRAC modulators
#375NOVEL THERAPY FOR PROSTATE CARCINOMA
#376Use of Adelmidrol in the Treatment of Epithelial Dysfunctions
#377Bacterial quorum sensing regulator and medical use thereof
#378BIOAVAILABLE COMPOSITIONS OF METAXALONE COMPRISING NONVOLATILE LIQUIDS AND PROCESSES FOR PRODUCING THE SAME
#379Traps in the treatment of macular degeneration
#380Supersaturated stabilized nanoparticles for poorly soluble drugs
#381Inhibition of choroidal neovascularization
#382Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
#383Compositions and methods of treating cardiac fibrosis with ifetroban
#384Dosage form for insertion into the mouth
#385Fatty acids as anti-inflammatory agents
#386Methods of treating muscular dystrophy
#387Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
#388Short-Term Infarction-Based Test for Investigative Drugs
#389METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS
#390Compositions and methods for treating mammary tumors
#391Hematopoietic growth factor mimetic small molecule compounds and their uses
#392Cell for electrolyzing a liquid
#393TREATMENT COMPOSITIONS
#394Therapeutic approaches for treating Parkinson's disease
#395LIM KINASE INHIBITORS
#396Compounds for use in the treatment of mycobacterial infections
#397Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC
#398METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES WITH CERAMIDE DERIVATIVES
#399Neprilysin inhibitors
#400PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#401Neprilysin inhibitors
#402Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseases
#403Aryloxyurea compound and pest control agent
#404Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
#405Mineralocorticoid receptor antagonists
#406AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#407Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
#408PDE10 inhibitors and related compositions and methods
#409Mutated fibroblast growth factor (FGF) 1 and methods of use
#410Methods of treating or preventing neuropathic pain
#411Cathepsin cysteine protease inhibitors
#412NEW COMPOUNDS
#413REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#414Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseases
#415Antiviral compounds and uses thereof
#416Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma
#417Inhibitors of cholesterol ester transfer protein
#418Lupane triterpenoid derivatives and pharmaceutical use thereof
#419TRPM8 antagonists
#420METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES
#421Pharmaceutical containing PPAR-delta agonist
#422Pharmaceutical composition for preventing or treating hyperlipidemia
#423Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
#424METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY
#425Dosage form for insertion into the mouth
#426Dosage form for insertion into the mouth
#427AGENT FOR INHIBITING EXPRESSION OF NPC1L1 AND/OR LIPG MRNA AND AGENT FOR PREVENTING AND/OR TREATING OBESITY
#428Novel formulation of metaxalone
#429Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
#430Dosage form for insertion into the mouth
#431COMPOSITION FOR ENHANCING TRANSDERMAL ABSORPTION OF DRUG AND PATCH PREPARATION
#432Dosage form for insertion into the mouth
#433PDE10 inhibitors and related compositions and methods
#434Cyclopropaneamine compound
#435POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS
#436CETP INHIBITORS
#437Dual-acting oxazole antihypertensive agents
#438Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
#439Short-Term Surrogate Test for Investigative Drugs
#440Anti-obesity agent comprising high-purity EPA
#441COMBINATIONS COMPRISING A DIPEPTIDYLPEPTIDASE - IV INHIBITOR
#442Compositions for Topical Application Having Androgenic Actions
#443Synthesis of intermediates for preparing anacetrapib and derivatives thereof
#444METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES
#445Aromatic amides and uses thereof
#446Method of treating atherosclerosis in high triglyceride subjects
#447Pyrazole compounds as CRTH2 antagonists
#448Sustained release pharmaceutical compositions comprising an antibacterial agent
#449METHODS OF TREATING OR PREVENTING ALZHEIMER'S DISEASE USING INDANE ACETIC ACID DERIVATIVES
#450Methods of treating muscular dystrophy
#451Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#452Neprilysin inhibitors
#453COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
#454Methods and compositions related to neuroactive thiazoline compounds
#455Alpha-ketoheterocycles and methods of making and using
#456Antispasmodic 1,2-Diols and 1,2,3-triols
#457Inhibition of choroidal neovascularization
#458Benzodioxane inhibitors of leukotriene production for combination therapy
#459Aryloxyurea compound and pest control agent
#460COMBINATIONS AND METHODS FOR TREATING NON AGE-RELATED HEARING IMPAIRMENT IN A SUBJECT
#461Methods and devices for providing prolonged drug therapy
#462Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
#463Dual-acting oxazole antihypertensive agents
#464PDE10 inhibitors and related compositions and methods
#465Methods and devices for providing prolonged drug therapy
#466Therapeutic agent or prophylactic agent for fibromyalgia
#467TREATMENT OF OPHTHALMIC CONDITIONS WITH FLUORENONE DERIVATIVES
#468Thromboxane A2 (TP) receptor antagonists
#469Metaxalone cocrystals
#470N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
#471Therapeutic agent or prophylactic agent for neuropathic pain
#472Oxazole and thiazole compounds as β-catenin modulators and uses thereof
#473Transglutaminase inhibitors and methods of use thereof
#474Substituted aminopropionic derivatives as neprilysin inhibitors
#475Lysophosphatidic acid receptor antagonists
#476Dosage form for insertion into the mouth
#4773-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#478Sulphone compounds and methods of making and using same
#479Therapeutic agent and preventative agent for alzheimer's disease
#480Therapeutic agent or preventive agent for urine collection disorder
#481Antimicrobial compositions and methods of use thereof
#482NEW COMPOUNDS
#483(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity
#484Pharmaceutical or veterinary antiviral compositions
#485Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
#486Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#487INHIBITION OF CHOROIDAL NEOVASCULARIZATION
#488Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
#489Hematopoietic growth factor mimetic small molecule compounds and their uses
#490Aryl ureas with angiogenesis inhibiting activity
#491ANTIBACTERIAL COMPOSITIONS
#492Compositions For Topical Application Having Androgenic Actions
#493Pharmaceutical containing PPAR delta agonist
#494Cyclohexane derivative and pharmaceutical use thereof
#495Compositions and soft tissue replacement methods
#496NOVEL FORMULATION OF METAXALONE
#497BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING PAIN
#498METHODS AND COMPOSITIONS FOR MODULATING RHO-MEDIATED GENE TRANSCRIPTION
#499Compounds for inflammation and immune-related uses
#500Pharmaceutical Compositions
#501PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#502Compositions and soft tissue replacement methods
#503Isoxazoline-substituted benzamide compound and pesticide
#504METHOD FOR IMPROVING THE DISSOLUTION PROFILE OF A BIOLOGICALLY ACTIVE MATERIAL
#505METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICRO PARTICLE POWDERS
#506Neprilysin inhibitors
#507Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
#508INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
#509LYSINE-SPECIFIC DEMETHYLASE 1(LSD1) IS A BIOMARKER FOR BREAST CANCER
#510Fatty acids as anti-inflammatory agents
#511COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES
#512Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
#513Method of treating contrast-induced nephropathy
#514ORAL METAXALONE COMPOSITIONS
#515Antiviral compounds and uses thereof
#516-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#517N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#518Isoxazoline compounds having MIF antagonist activity
#519INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
#520MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#521Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#522Antiviral Compounds and Methods of Using Thereof
#523Pharmaceutical combination
#524BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING METABOLIC DISORDERS
#525Thiazole and oxazole-substituted arylamides as P2Xand P2Xantagonists
#526PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#527OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1
#528N-acyl anthranilic acid derivative or salt thereof
#529Compositions and Methods Related to Acid Stable Lipid Nanospheres
#530Isoxazoline-substituted benzamide compound and pesticide
#531Compositions and methods for the treatment of somatosensory disorders
#532MEDICAMENTS
#533PDE10 inhibitors and related compositions and methods
#534Cyclohexane derivative and pharmaceutical use thereof
#535Polysaccharide Based Antimicrobial Formulations
#536METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION
#537Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
#538Compositions and Methods for Preventing Migraines
#5394,5-dihydro-oxazol-2yl derivatives
#540Inhibitors of the plasmodial surface anion channel as antimalarials
#5412-oxothiazole compounds and method of using same for chronic inflammatory disorders
#542Immunomodulation by IAP inhibitors
#543Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
#544Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders
#545BIOAVAILABLE COMPOSITIONS OF METAXALONE AND PROCESSES FOR PRODUCING THE SAME
#546Agent for Enhancing Corneal Epithelial Barrier Function
#547Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases
#548IMIDAZOLE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M3
#549Use of thioflavin-like compounds to increase life span and/or health span
#550LIPOSOMES ENCAPSULATING AN OXAZOLIDIN-2-ONE COMPOUND
#551INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I
#552Compositions for Topical Application Having Androgenic Actions
#553Metaxalone products, method of manufacture, and method of use
#554Methods of treating vasodilatory shock
#555COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST
#55617BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES
#557N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#558NPY Y5 ANTAGONIST
#559Dual-acting oxazole antihypertensive agents
#560Aryl ureas with angiogenisis inhibiting activity
#561MODULATORS OF PARAPTOSIS AND RELATED METHODS
#562Substituted aminopropionic derivatives as neprilysin inhibitors
#563Phenylsulfoxyoxazole compound inhibitors of urea transporters
#564Use of oxazole derivatives for controlling fish parasites
#565Method of treating polycystic kidney diseases with ceramide derivatives
#566NPY Y5 antagonist
#567Medicaments
#568Inflammatory cytokine release inhibitor
#569Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
#570LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER
#571Fluorene compound and pharmaceutical use thereof
#572New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
#573BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#574Method for modulating microbial quorum sensing
#575Repeated Dosing of TRPV1 Antagonists
#576BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING METABOLIC DISORDERS
#577PHARMACEUTICAL CONTAINING PPARA AGONIST
#578MODULATION OF NEUROGENESIS BY PPAR AGENTS
#579COMPOSITONS AND METHOD FOR TREATMENT OF MOOD AND COGNITIVE IMPAIRMENTS
#580COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES
#581Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypertension
#582COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES
#583COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES
#584Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
#585Dosage form for insertion into the mouth
#586METHOD FOR TREATING METABOLIC DISEASES
#587BIOAVAILABLE COMPOSITIONS OF METAXALONE AND PROCESSES FOR PRODUCING THE SAME
#588CETP inhibitors
#589Methods and devices for providing prolonged drug therapy
#590Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
#591POLYAMINO ACID DERIVATIVES AND USE THEREOF IN COMPOSITIONS FOR TREATING KERATIN FIBERS
#592Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#593METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
#5944,5-dihydro-oxazol-2YL derivatives
#595Isoxazoline compounds having MIF antagonist activity
#596Compounds for treatment of cancer
#597Isoxazoline-substituted benzamide compound and pesticide
#598Transglutaminase inhibitors and methods of use thereof
#599α2B and α2C agonists
#600METHODS OF TREATING ISCHEMIC RELATED CONDITIONS